Sara W. Burris

Security Threat Groups (White)

J. M. Miller, Sara W. Burris, 2017 .

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Rebecca M. Baker, Phuong Thi Tuyet Nguyen, Carol L. Eyler, 2021, The Lancet Infectious Diseases.

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.

Michael L. Nelson, Brad T. Sherman, I. Douglas, 2023, The Lancet. Respiratory medicine.

Second Chance Act, The

Sara W. Burris, J. M. Miller, 2017 .